Jundishapur Journal of Natural Pharmaceutical Products

Published by: Kowsar

Drug Hypersensitivity Reactions in Hospital-Admitted Children: A Single Center Study in Southern Iran

Hesamodin Nabavizadeh 1 , 2 , Soheyla Alyasin 1 , 2 , Hamidreza Houshmand 2 , 3 , * , Gholamreza Houshmand 4 , Mohammad Bahadoram 5 , Sara Bayat 6 , Hossein Esmaeilzadeh 1 , 2 and Mehdi Goudarzi 7
Authors Information
1 Department of Allergy and Clinical Immunology, Shiraz University of Medical Sciences, Shiraz, Iran
2 Allergy Research Center, Shiraz University of Medical Sciences, Shiraz, Iran
3 Department of Pediatrics, Division of Allergy and Clinical Immunology, School of Medicine, Urmia University of Medical Sciences, Urmia, Iran
4 Department of Pharmacology, School of Medicine, Mazandaran University of Medical Sciences, Sari, Iran
5 Medical Student Research Committee and Social Determinant of Health Research center, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran
6 Medical Student Research Committee, Mazandaran University of Medical Sciences, Sari, Iran
7 Medicinal Plant Research Center, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran
Article information
  • Jundishapur Journal of Natural Pharmaceutical Products: May 2018, 13 (2); e13981
  • Published Online: May 14, 2018
  • Article Type: Research Article
  • Received: November 29, 2016
  • Revised: May 24, 2017
  • Accepted: March 10, 2018
  • DOI: 10.5812/jjnpp.13981

To Cite: Nabavizadeh H, Alyasin S, Houshmand H, Houshmand G, Bahadoram M, et al. Drug Hypersensitivity Reactions in Hospital-Admitted Children: A Single Center Study in Southern Iran, Jundishapur J Nat Pharm Prod. 2018 ; 13(2):e13981. doi: 10.5812/jjnpp.13981.

Copyright © 2018, Jundishapur Journal of Natural Pharmaceutical Products. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited
1. Background
2. Objectives
3. Methods
4. Results
5. Discussion
  • 1. Adkinson Jr NF, Bochner BS, Burks AW, Busse WW, Holgate ST, Lemanske Jr RF. Middleton's allergy: principles and practice. Elsevier Health Sciences; 2013. p. 1274-95.
  • 2. Chiriac AM, Demoly P. Drug allergy diagnosis. Immunol Allergy Clin North Am. 2014;34(3):461-71. vii. doi: 10.1016/j.iac.2014.03.002. [PubMed: 25017672].
  • 3. Dona I, Barrionuevo E, Blanca-Lopez N, Torres MJ, Fernandez TD, Mayorga C, et al. Trends in hypersensitivity drug reactions: more drugs, more response patterns, more heterogeneity. J Investig Allergol Clin Immunol. 2014;24(3):143-53. quiz 1 p following 153. [PubMed: 25011351].
  • 4. Khan DA, Solensky R. Drug allergy. J Allergy Clin Immunol. 2010;125(2 Suppl 2):S126-37. doi: 10.1016/j.jaci.2009.10.028. [PubMed: 20176256].
  • 5. Levi N, Bastuji-Garin S, Mockenhaupt M, Roujeau JC, Flahault A, Kelly JP, et al. Medications as risk factors of Stevens-Johnson syndrome and toxic epidermal necrolysis in children: a pooled analysis. Pediatrics. 2009 2;123(2 Suppl 2). e297-304. doi: 10.1542/peds.2008-1923. [PubMed: 19153164].
  • 6. Pichler WJ. The p-i Concept: Pharmacological Interaction of Drugs With Immune Receptors. World Allergy Organ J. 2008;1(6):96-102. doi: 10.1097/WOX.0b013e3181778282. [PubMed: 23282405]. [PubMed Central: PMC3651037].
  • 7. Kardaun SH, Sidoroff A, Valeyrie-Allanore L, Halevy S, Davidovici BB, Mockenhaupt M, et al. Variability in the clinical pattern of cutaneous side-effects of drugs with systemic symptoms: does a DRESS syndrome really exist? Br J Dermatol. 2007;156(3):609-11. doi: 10.1111/j.1365-2133.2006.07704.x. [PubMed: 17300272].
  • 8. Cano FG, Rozenfeld S. Adverse drug events in hospitals: a systematic review. Cad Saude Publica. 2009;25 Suppl 3:S360-72. doi: 10.1590/S0102-311X2009001500003. [PubMed: 20027385].
  • 9. Pirmohamed M, James S, Meakin S, Green C, Scott AK, Walley TJ, et al. Adverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patients. BMJ. 2004;329(7456):15-9. doi: 10.1136/bmj.329.7456.15. [PubMed: 15231615]. [PubMed Central: PMC443443].
  • 10. Marrs T, Fox AT, Lack G, du Toit G. The diagnosis and management of antibiotic allergy in children: Systematic review to inform a contemporary approach. Arch Dis Child. 2015;100(6):583-8. doi: 10.1136/archdischild-2014-306280. [PubMed: 25527519].
  • 11. Turk BG, Gunaydin A, Ertam I, Ozturk G. Adverse cutaneous drug reactions among hospitalized patients: five year surveillance. Cutan Ocul Toxicol. 2013;32(1):41-5. doi: 10.3109/15569527.2012.702837. [PubMed: 22812902].
  • 12. Fernandez TD, Mayorga C, Ariza A, Corzo JL, Torres MJ. Allergic reactions to antibiotics in children. Curr Opin Allergy Clin Immunol. 2014;14(4):278-85. doi: 10.1097/ACI.0000000000000069. [PubMed: 24848090].
  • 13. Karimzadeh P, Bakrani V. Antiepileptic drug-related adverse reactions and factors influencing these reactions. Iran J Child Neurol. 2013;7(3):25-9. [PubMed: 24665302]. [PubMed Central: PMC3943074].
  • 14. Langerova P, Vrtal J, Urbanek K. Adverse drug reactions causing hospital admissions in childhood: a prospective, observational, single-centre study. Basic Clin Pharmacol Toxicol. 2014;115(6):560-4. doi: 10.1111/bcpt.12264. [PubMed: 24810357].
  • 15. Kourouma HS, Kouassi YI, Diabate A, Sangare A, Ecra EJ, Kaloga M, et al. [Clinical-epidemiological profile of severe cutaneous drug reactions in children in Abidjan (Cote d'Ivoire)]. Bull Soc Pathol Exot. 2014;107(3):142-5. doi: 10.1007/s13149-014-0360-y. [PubMed: 24792460].
  • 16. Dilek N, Ozkol HU, Akbas A, Kilinc F, Dilek AR, Saral Y, et al. Cutaneous drug reactions in children: a multicentric study. Postepy Dermatol Alergol. 2014;31(6):368-71. doi: 10.5114/pdia.2014.43881. [PubMed: 25610351]. [PubMed Central: PMC4293388].
  • 17. Esmaeilzadeh H, Nabavi M, Aryan Z, Amirzargar AA. Pharmacogenetic tests to predict the efficacy of aspirin desensitization in patients with aspirin-exacerbated respiratory diseases; HLA-DQB302. Expert Rev Respir Med. 2015 10;9(5):511-8. doi: 10.1586/17476348.2015.1081062. [PubMed: 26366802].
  • 18. Mortazavi N, Esmaeilzadeh H, Abbasinazari M, Babaie D, Alyasin S, Nabavizadeh H, et al. Clinical and Immunological Efficacy of Aspirin Desensitization in Nasal Polyp Patients with Aspirin-Exacerbated Respiratory Disease. Iran J Pharm Res. 2017;16(4):1639-47. [PubMed: 29552073]. [PubMed Central: PMC5843326].
  • 19. Nabavi M, Arshi S, Bemanian MH, Aghamohammadi A, Mansouri D, Hedayat M, et al. Long-term follow-up of ninety eight Iranian patients with primary immune deficiency in a single tertiary centre. Allergol Immunopathol (Madr). 2016;44(4):322-30. doi: 10.1016/j.aller.2015.09.006. [PubMed: 26803694].
  • 20. Nabavi M, Arshi S, Bemanian MH, Shakeri R, Taghvaei B, Ghalebaghi B, et al. Long-term follow-up of ninety-eight Iranian patients with primary immune deficiency in a single tertiary centre. Allergol Immunopathol. 2016;44(4):322-30. doi: 10.1016/j.aller.2015.09.006. [PubMed: 26803694].

Featured Image:

Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments